FDA Advisers to Vote on Target Variant for COVID Shot

Published on June 3, 2024

Advisers to the U.S. Food and Drug Administration will vote whether to recommend that COVID-19 vaccines for 2024-25 should target the JN.1 variant, the most dominant this year, documents filed on Monday showed. Shares of Novavax soared 11% in morning trade, after the…

Read Full Article (External Site)